Sysmex (OTCMKTS:SSMXY) Trading Down 0.6% - Here's Why

Sysmex Co. (OTCMKTS:SSMXY - Get Free Report) shares were down 0.6% during trading on Friday . The stock traded as low as $16.15 and last traded at $16.19. Approximately 66,045 shares changed hands during mid-day trading, a decline of 8% from the average daily volume of 71,536 shares. The stock had previously closed at $16.28.

Sysmex Trading Up 1.3%

The company has a market cap of $10.32 billion, a PE ratio of 29.29 and a beta of 1.14. The company has a 50-day moving average of $17.83 and a 200 day moving average of $18.53. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.19 and a quick ratio of 2.42.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last issued its quarterly earnings results on Wednesday, May 14th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.16 by ($0.04). The company had revenue of $958.89 million during the quarter, compared to the consensus estimate of $991.22 million. Analysts predict that Sysmex Co. will post 0.57 earnings per share for the current year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.